Ceapro Inc. (CVE:CZO – Get Free Report) shares dropped 11.8% on Tuesday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Down 11.8%
The company has a debt-to-equity ratio of 8.07, a quick ratio of 18.88 and a current ratio of 8.54. The stock has a market cap of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38. The firm’s 50-day simple moving average is C$0.22 and its two-hundred day simple moving average is C$0.23.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
